Orchestra BioMed
OBIO
OBIO
24 hedge funds and large institutions have $56.6M invested in Orchestra BioMed in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$748K | |
| 2 | +$649K | |
| 3 | +$267K | |
| 4 |
RL
RPO LLC
Stamford,
Connecticut
|
+$35.5K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$387K | |
| 3 | -$28K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$13.5K |
| 5 |
Morgan Stanley
New York
|
-$1K |